Chemed Corp (CHE)

Sep 21, 2026

Kevin Mcnamara, President and CEO of Chemed Corp (CHE), sold 2,000 shares of the company, continuing a pattern of insider selling over the past year. While insider activity shows 13 sells and 0 buys, the stock is considered "Modestly Undervalued" by GuruFocus's GF Value, and 7 gurus hold shares, with more adding than trimming. This creates a nuanced picture for investors, suggesting personal financial planning may be a factor in the insider sale rather than a lack of confidence in the company.

Sep 21, 2026

Chemed CEO Kevin Mcnamara sold 2,000 shares of the company's stock for approximately $1.0 million, reducing his stake by 2.84%. Following the sale, Chemed's shares fell by 1.3%, though the company recently reported strong quarterly earnings that surpassed estimates and increased its quarterly dividend. Institutional investors hold a significant portion of the stock, and analysts currently have a consensus "Hold" rating with an average price target of $530.75.

Sep 21, 2026

Bank of America Corp DE has acquired a new stake of 103,610 shares in Chemed Corporation (NYSE:CHE) during the second quarter, valued at approximately $48.3 million, giving them a 0.79% ownership. This move comes as Chemed reported strong quarterly results, beating analyst expectations with EPS of $6.06 and revenue of $673.25 million, an 8.8% year-over-year increase, and subsequently raised its quarterly dividend. Despite these positive indicators, analysts maintain a "Hold" rating with an average price target of $530.75 for the stock.

Sep 18, 2026

Chemed Corporation (NYSE:CHE) is attracting attention due to its unusual business model, combining hospice and palliative care through VITAS Healthcare with plumbing and water restoration services via Roto-Rooter. This diversification, along with strong quarterly financial performance that surpassed market estimates and a recent dividend increase, has brought the company into focus. Its unique structure provides exposure to distinct demand patterns in both healthcare and essential home services, setting it apart in the market.

Sep 18, 2026

Chemed Corporation (NYSE:CHE) has received an average "Hold" recommendation from brokerages, with five out of six analysts rating the stock neutral and one recommending a buy. The average 12-month price target is $530.75. The company recently reported strong quarterly results, exceeding EPS and revenue expectations, and increased its quarterly dividend.